SCHEMBL19081983

SCHEMBL19081983

c1cc(-c2ccc3sc4cc5oc6ccc7ccccc7c6c5cc4c3c2)cc(-c2c3ccccc3c(-c3ccc4ccccc4c3)c3ccccc23)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 7/20 0.35
AHR P35869 2/20 0.35
PAX8 Q06710 2/20 0.35
CYP1A1 P04798 2/20 0.35
CYP1A2 P05177 1/20 0.35
FYN P06241 1/20 0.35
MAPK3 P27361 1/20 0.35
NPC1 O15118 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
RAB9A P51151 1/20 0.33
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
CYP1B1 Q16678 1/20 0.32
PLA2G10 O15496 1/20 0.31
PLA2G2A P14555 1/20 0.31
PLA2G4A P47712 1/20 0.31
S1PR4 O95977 1/20 0.31
S1PR5 Q9H228 1/20 0.31
NQO1 P15559 1/20 0.30
NQO2 P16083 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081836 1.00 ABCG2 (0.35) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL19081978 0.96 ABCG2 (0.35) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL19081941 0.92 ABCG2 (0.34) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL19082012 0.90 ABCG2 (0.38) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL19081813 0.90 ABCG2 (0.40) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL17932254 0.89 PLA2G2A (0.34) RAB9AHSD17B1HSD17B2PLA2G10PLA2G2A
SCHEMBL17945526 0.89 PLA2G2A (0.34) RAB9AHSD17B1HSD17B2PLA2G10PLA2G2A
SCHEMBL24342604 0.88 PLA2G2A (0.35) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL19081878 0.88 ABCG2 (0.38) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL19081944 0.87 ABCG2 (0.34) ABCG2AHRPAX8CYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ABCG2 4823/4885AHR 2453/4885PAX8 2336/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ABCG2 4823/4885AHR 2453/4885PAX8 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.